SCHEMBL1371070

SCHEMBL1371070

O=C(CCl)CCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.61
▸ ALDH1A1 P00352 2/20 0.57
▸ FFAR1 O14842 1/20 0.57
▸ TDP1 Q9NUW8 3/20 0.55
▸ TRPA1 O75762 2/20 0.55
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ HDAC2 Q92769 2/20 0.53
▸ HDAC8 Q9BY41 2/20 0.53
▸ HDAC6 Q9UBN7 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ HDAC1 Q13547 2/20 0.52
▸ HDAC3 O15379 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ ADRA1A P35348 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8187637 0.88 HDAC1 (0.64) KEAP1TDP1L3MBTL1HDAC2HDAC8
SCHEMBL497371 0.86 KEAP1 (0.73) KEAP1ALDH1A1FFAR1TDP1TRPA1
SCHEMBL11741034 0.85 KEAP1 (0.59) KEAP1ALDH1A1FFAR1TDP1TRPA1
SCHEMBL712597 0.84 KEAP1 (0.70) KEAP1ALDH1A1FFAR1TDP1TRPA1
SCHEMBL107423 0.84 KEAP1 (0.70) KEAP1ALDH1A1FFAR1TDP1TRPA1
SCHEMBL5598977 0.82 KEAP1 (0.67) KEAP1ALDH1A1FFAR1TDP1TRPA1
SCHEMBL11199625 0.82 KEAP1 (0.55) KEAP1ALDH1A1FFAR1TDP1TRPA1
SCHEMBL11176136 0.81 PLAAT3 (0.50) ALDH1A1FFAR1L3MBTL1HDAC2HDAC8
SCHEMBL29270416 0.81 PLAAT5 (0.59) KEAP1ALDH1A1FFAR1TDP1HDAC2
Phenylethyl Alcohol SCHEMBL28312217 0.81 TDP1 (0.67) KEAP1ALDH1A1FFAR1TDP1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552788-B2 IMDQ-PEG-CHOL adjuvant and uses thereof ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2026-02-17 — — US disclosed
EP-4241785-B1 INFLUENZA VIRUS VACCINES AND USES THEREOF ICAHN SCHOOL MED MOUNT SINAI (US) 2026-01-28 — — EP disclosed
US-20260001918-A1 INFLUENZA VIRUS VACCINES AND USES THEREOF ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2026-01-01 — — US disclosed
WO-2025231514-A1 ANTIVIRAL FORMULATIONS Vapour Science (AU) 2025-11-13 — — WO disclosed
CN-117164418-B Alpha-halogenated ketone, efficient synthesis method and application thereof 徐州医科大学 2024-07-02 — — CN disclosed
US-20240116889-A1 ANTIVIRAL COMPOUNDS AND METHODS THE UNIVERSITY OF NOTTINGHAM (GB) 2024-04-11 — — US disclosed
CN-117164418-A Alpha-halogenated ketone, efficient synthesis method and application thereof 徐州医科大学 2023-12-05 — — CN disclosed
US-20230373997-A1 IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-11-23 — — US disclosed
EP-4241785-A2 INFLUENZA VIRUS VACCINES AND USES THEREOF Icahn School of Medicine at Mount Sinai (US) 2023-09-13 — — EP disclosed
EP-4225366-A1 IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF Icahn School of Medicine at Mount Sinai (US) 2023-08-16 — — EP disclosed
US-5474700-A Cleaning composition for degrading targeted proteinaceous contaminants THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1995-12-12 — — US disclosed
US-5409941-A 5-heteroyl indole derivatives PFIZER INC. (US) 1995-04-25 — — US disclosed
US-5312749-A Industrial alkaline protease from shipworm bacterium THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1994-05-17 — — US disclosed
EP-0571471-A1 5-HETEROYL INDOLE DERIVATIVES. PFIZER (US) 1993-12-01 — — EP disclosed
EP-0502892-A4 THE HUMAN C3B/C4B RECEPTOR (CR1) — 1992-11-19 — — EP disclosed
EP-0502892-A1 THE HUMAN C3b/C4b RECEPTOR (CR1) THE JOHNS HOPKINS UNIVERSITY (US) 1992-09-16 — — EP disclosed
WO-1992013856-A1 5-HETEROYL INDOLE DERIVATIVES PFIZER INC. (US) 1992-08-20 — — WO disclosed
WO-1991005047-A1 THE HUMAN C3b/C4b RECEPTOR (CR1) THE JOHNS HOPKINS UNIVERSITY (US) 1991-04-18 — — WO disclosed
US-4375474-A BACTERICIDES, FUNGICIDES SYNTEX (U.S.A.) INC. (US) 1983-03-01 — — US disclosed
US-4153606-A Process for the production of thiazoline-(3) compounds DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) 1979-05-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552788-B2 IMDQ-PEG-CHOL adjuvant and uses thereof ICOS, MYD88, TLR7 KEAP1 912/4885ALDH1A1 4216/4885FFAR1 2792/4885
US-20240116889-A1 ANTIVIRAL COMPOUNDS AND METHODS IFNAR1, EIF2AK2, ZC3HAV1 KEAP1 2305/4885ALDH1A1 1769/4885FFAR1 3286/4885
US-20230373997-A1 IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF LY96, MYD88, CD14 KEAP1 782/4885ALDH1A1 4605/4885FFAR1 3257/4885
US-20260001918-A1 INFLUENZA VIRUS VACCINES AND USES THEREOF CD44, SIGLEC7, SIGLEC9 KEAP1 4677/4885ALDH1A1 3606/4885FFAR1 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback